These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2167040)

  • 1. In vitro inhibition of bacterial DNA gyrase by cinodine, a glycocinnamoylspermidine antibiotic.
    Osburne MS; Maiese WM; Greenstein M
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1450-2. PubMed ID: 2167040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of cinodine, a glycocinnamoylspermidine antibiotic.
    Greenstein M; Speth JL; Maiese WM
    Antimicrob Agents Chemother; 1981 Oct; 20(4):425-32. PubMed ID: 6177279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a cinodine-resistant mutant of Escherichia coli.
    Osburne MS
    J Antibiot (Tokyo); 1995 Nov; 48(11):1359-61. PubMed ID: 8557583
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of DNA gyrase by optically active ofloxacin.
    Imamura M; Shibamura S; Hayakawa I; Osada Y
    Antimicrob Agents Chemother; 1987 Feb; 31(2):325-7. PubMed ID: 3032098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of the spermidine moiety of glycocinnamoylspermidine antibiotic cinodine.
    Chiu SH; Fiala R; Bullock MW
    J Antibiot (Tokyo); 1984 Sep; 37(9):1079-81. PubMed ID: 6501105
    [No Abstract]   [Full Text] [Related]  

  • 6. Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones.
    Fu KP; Grace ME; McCloud SJ; Gregory FJ; Hung PP
    Chemotherapy; 1986; 32(6):494-8. PubMed ID: 3026740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of the glycocinnamoylspermidine antibiotic, cinodine.
    Chiu SH; Fiala R; Kennett R; Wozniak L; Bullock MW
    J Antibiot (Tokyo); 1984 Sep; 37(9):1000-6. PubMed ID: 6501101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarins as inhibitors of bacterial DNA gyrase.
    Althaus IW; Dolak L; Reusser F
    J Antibiot (Tokyo); 1988 Mar; 41(3):373-6. PubMed ID: 2835349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids.
    Zweerink MM; Edison A
    Antimicrob Agents Chemother; 1986 Apr; 29(4):598-601. PubMed ID: 3010848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
    Metwally NH; Abdallah SO; Mohsen MMA
    Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance.
    Hooper DC
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S54-63. PubMed ID: 9710672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of the spermidine and guanidino units in the glycocinnamoylspermidine antibiotic cinodine.
    Tsou HR; Fiala RR; Mowery PC; Bullock MW
    J Antibiot (Tokyo); 1984 Nov; 37(11):1382-7. PubMed ID: 6511665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.
    Blanche F; Cameron B; Bernard FX; Maton L; Manse B; Ferrero L; Ratet N; Lecoq C; Goniot A; Bisch D; Crouzet J
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclothialidine and its congeners: a new class of DNA gyrase inhibitors.
    Goetschi E; Angehrn P; Gmuender H; Hebeisen P; Link H; Masciadri R; Nielsen J
    Pharmacol Ther; 1993 Nov; 60(2):367-80. PubMed ID: 8022866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of closthioamide: the first member of the polythioamide class of bacterial DNA gyrase inhibitors.
    Chiriac AI; Kloss F; Krämer J; Vuong C; Hertweck C; Sahl HG
    J Antimicrob Chemother; 2015 Sep; 70(9):2576-88. PubMed ID: 26174721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
    Domagala JM; Hanna LD; Heifetz CL; Hutt MP; Mich TF; Sanchez JP; Solomon M
    J Med Chem; 1986 Mar; 29(3):394-404. PubMed ID: 3005575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CJ-12,371 and CJ-12,372, two novel DNA gyrase inhibitors. Fermentation,isolation, structural elucidation and biological activities.
    Sakemi S; Inagaki T; Kaneda K; Hirai H; Iwata E; Sakakibara T; Yamauchi Y; Norcia M; Wondrack LM; Sutcliffe JA
    J Antibiot (Tokyo); 1995 Feb; 48(2):134-42. PubMed ID: 7706123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity.
    Fois B; Skok Ž; Tomašič T; Ilaš J; Zidar N; Zega A; Peterlin Mašič L; Szili P; Draskovits G; Nyerges Á; Pál C; Kikelj D
    ChemMedChem; 2020 Feb; 15(3):265-269. PubMed ID: 31721445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial DNA topoisomerases and their inhibition by antibiotics.
    Zimmer C; Störl K; Störl J
    J Basic Microbiol; 1990; 30(3):209-24. PubMed ID: 2164580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
    Gjorgjieva M; Tomašič T; Barančokova M; Katsamakas S; Ilaš J; Tammela P; Peterlin Mašič L; Kikelj D
    J Med Chem; 2016 Oct; 59(19):8941-8954. PubMed ID: 27541007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.